Post-traumatic stress disorder associated with cancer diagnosis and treatment Book Section
| Authors: | Doolittle, M. N.; Duhamel, K. N. |
| Editors: | Holland, J. C.; Breitbart, W. S.; Butow, P. N.; Jacobsen, P. B.; Loscalzo, M. J.; McCorkle, R. |
| Article/Chapter Title: | Post-traumatic stress disorder associated with cancer diagnosis and treatment |
| Abstract: | (from the chapter) Post-traumatic stress disorder (PTSD) is a constellation of symptoms occurring in response to a traumatic event. PTSD was first recognized as a formal psychiatric disorder in 1980 in the third edition of the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders (DSM-III). However, the notion that exposure to a significant stressor could trigger a severe and dysfunctional psychological response has a much longer history. Historically linked to warfare, PTSD has also been associated wfth significant civilian stressors such as assault, motor vehicle accidents (MVAs), and natural disasters. In 1994, the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) specified that a life-threatening illness, such as malignant disease, could also serve as a traumatic event capable of precipitating PTSD. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders, published in 2013, continues to identify "life-threatening illness or debilitating medical condition" as a possible traumatic event. Since the first inclusion of medical illness as a potential trigger to PTSD in the DSM-IV, a large scientific literature has emerged examining PTSD associated with cancer diagnosis and treatment, and research has focused both on prevalence of PTSD symptoms and diagnoses in adult and child cancer patients and survivors , a n d increasingly on family members and others affected more indirectly by the cancer. The possibility that notification of carrier status for genes associated with hereditary cancer syndromes has also been investigated. The subset of literature on PTSD and malignancy that incorporates instruments with reported validity in identifying PTSD is growing; however, even among studies utilizing these instruments, many focus primarily on symptoms or distress without identifying a formal disorder. The use of various endpoints and instruments, as well as various exposures evaluated at different time points, further complicates interpretation of the literature and identification of prevalence of PTSD. Significant changes in formal criteria for identifying PTSD in DSM-5 may make this literature even harder to interpret. (PsycINFO Database Record (c) 2015 APA, all rights reserved). |
| Keywords: | cancer diagnosis; post-traumatic stress disorder; medical condition; traumatic event |
| Book Title: | Psycho-Oncology. 3rd ed |
| ISBN: | 978-0-19-936331-5 |
| Publisher: | Oxford University Press |
| Publication Place: | Oxford, UK |
| Date Published: | 2015-01-01 |
| Start Page: | 323 |
| End Page: | 338 |
| Language: | English |
| ACCESSION: | Book: 2014-48591-042 |
| DOI: | 10.1093/med/9780199363315.003.0042 |
| PROVIDER: | Ovid Technologies |
| PROVIDER: | psycinfo |
| DOI/URL: | |
| Notes: | Book Chapter: 42 -- Source: PsycINFO |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work